Account
Inquiry
Tirzepatide is a novel dual agonist peptide targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This innovative compound has shown significant potential in metabolic research applications.
As a research chemical, Tirzepatide demonstrates multiple physiological effects including appetite suppression, gastric emptying delay, and insulin secretion stimulation. The peptide features a modified lysine side chain with PEGylation to enhance water solubility and stability.
In preclinical studies, Tirzepatide has shown promising results in glucose regulation and weight management research. The compound represents an advanced approach in metabolic disorder investigation by combining two incretin effects in a single molecule.
Researchers interested to buy Tirzepatide should note it is supplied as a white lyophilized powder in sterile vials. Proper storage at -20°C is recommended to maintain stability. Each batch undergoes rigorous quality control testing to ensure 99% purity.
This product is intended for laboratory research purposes only. Not for human consumption. Researchers must follow all applicable regulations and guidelines when handling this material.
